Zacks Research Research Analysts Raise Earnings Estimates for Allogene Therapeutics, Inc. (NASDAQ:ALLO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Citigroup started coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a research note released on Friday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $7.00 target price on the stock. ALLO has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their […]
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) will be announcing its earnings results after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.53) per share for the quarter. Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.53) […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.88 and last traded at $3.03, with a volume of 486164 shares changing hands. The stock had previously closed at $3.08. Analysts Set New Price Targets A number of brokerages […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.88 and last traded at $3.00, with a volume of 1531650 shares traded. The stock had previously closed at $3.16. Analyst Ratings Changes ALLO has been the topic […]